CORT
Corcept Therapeutics Incorporated
114.70$
-0.8%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -103.1% | 6.2% | 22.6% | 38.3% | 46.0% | 44.4% | 42.9% | 45.9% | 29.9% | 26.3% | 29.3% | 18.6% | |
| 0.5% | 0.3% | 0.1% | 0.1% | 0.1% | 0.7% | 0.6% | 0.8% | 0.9% | 0.5% | 0.2% | 0.2% | |
| 19.6% | 12.0% | 8.7% | 8.4% | 9.5% | 9.6% | 9.5% | 11.7% | 10.6% | 10.1% | 9.1% | 11.1% | |
| 19.6% | 12.0% | 8.7% | -39.6% | 15.1% | 15.1% | 13.5% | 12.9% | 2.5% | – | – | – | |
| -19.0% | 1.0% | 1.4% | -3.6% | 1.6% | -1.5% | -1.5% | 0.0% | 1.4% | 1.7% | 6.7% | -3.6% | |
| 0.7% | 0.0% | 0.2% | 0.3% | 0.1% | 0.4% | 0.3% | 0.1% | 0.1% | 0.0% | 0.3% | 0.0% | |
| -0.7% | 0.0% | -0.2% | -46.1% | -36.1% | -38.4% | -33.7% | 37.2% | -28.4% | 18.8% | -26.3% | 9.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 2.3% | 6.1% | 3.9% | 5.9% | – | – | – | |
| 6.7% | 44.3% | 9.4% | 4.5% | -9.4% | -10.1% | -2.8% | -80.9% | -5.4% | -30.1% | -2.3% | -32.3% | |
| -18.3% | -18.3% | -18.2% | -9.5% | – | – | – | – | – | – | – | – | |
| -11.6% | 26.0% | -8.7% | -5.0% | -5.7% | -9.3% | 3.5% | -82.7% | -4.3% | -30.8% | -4.2% | -28.9% | |
| -115.4% | 32.2% | 13.7% | -12.9% | 4.2% | -3.4% | 12.7% | 0.4% | -2.8% | 14.4% | -1.2% | -0.9% | |
| -103.8% | 6.2% | 22.4% | 38.0% | 45.9% | 44.1% | 42.6% | 45.7% | 29.8% | 26.3% | 29.0% | 18.6% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.